Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Pharmaceutical Statistics
|
August 6, 2016
Choosing estimands in clinical trials with missing data
Craig Mallinckrodt, Geert Molenberghs, Suchitrita Rathmann
Archives of General Psychiatry
|
December 8, 2011
Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses
Ralitza Gueorguieva, Craig Mallinckrodt, John H Krystal
Biometrics
|
July 5, 2007
A latent-class mixture model for incomplete longitudinal Gaussian data
Caroline Beunckens, Geert Molenberghs, Geert Verbeke, et al.
Journal of Biopharmaceutical Statistics
|
May 27, 2006
A local influence sensitivity analysis for incomplete longitudinal depression data
Shuyi Shen, Caroline Beunckens, Craig Mallinckrodt, et al.
Pharmaceutical Statistics
|
April 7, 2018
An evaluation of the trimmed mean approach in clinical trials with dropout
Ming-Dauh Wang, Jiajun Liu, Geert Molenberghs, et al.
The Journal of Nervous and Mental Disease
|
April 16, 2003
Placebo response and antidepressant clinical trial outcome
Arif Khan, Michael Detke, Shirin R F Khan, et al.
The Journal of Sexual Medicine
|
July 14, 2007
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder
Anita Clayton, Susan Kornstein, Apurva Prakash, et al.
The Journal of Clinical Psychiatry
|
April 3, 2002
Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial
David J Goldstein, Craig Mallinckrodt, Yili Lu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Kent Hendrix, Craig Mallinckrodt, Suzanne B Hendrix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Craig Mallinckrodt, Suzanne B Hendrix, Kent Hendrix, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Pharmaceutical Statistics
|
August 6, 2016
Choosing estimands in clinical trials with missing data
Craig Mallinckrodt, Geert Molenberghs, Suchitrita Rathmann
Archives of General Psychiatry
|
December 8, 2011
Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses
Ralitza Gueorguieva, Craig Mallinckrodt, John H Krystal
Biometrics
|
July 5, 2007
A latent-class mixture model for incomplete longitudinal Gaussian data
Caroline Beunckens, Geert Molenberghs, Geert Verbeke, et al.
Journal of Biopharmaceutical Statistics
|
May 27, 2006
A local influence sensitivity analysis for incomplete longitudinal depression data
Shuyi Shen, Caroline Beunckens, Craig Mallinckrodt, et al.
Pharmaceutical Statistics
|
April 7, 2018
An evaluation of the trimmed mean approach in clinical trials with dropout
Ming-Dauh Wang, Jiajun Liu, Geert Molenberghs, et al.
The Journal of Nervous and Mental Disease
|
April 16, 2003
Placebo response and antidepressant clinical trial outcome
Arif Khan, Michael Detke, Shirin R F Khan, et al.
The Journal of Sexual Medicine
|
July 14, 2007
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder
Anita Clayton, Susan Kornstein, Apurva Prakash, et al.
The Journal of Clinical Psychiatry
|
April 3, 2002
Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial
David J Goldstein, Craig Mallinckrodt, Yili Lu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Kent Hendrix, Craig Mallinckrodt, Suzanne B Hendrix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Craig Mallinckrodt, Suzanne B Hendrix, Kent Hendrix, et al.
Page
of 4